Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

August 28, 2021

Study Completion Date

September 30, 2021

Conditions
Communication
Interventions
BEHAVIORAL

Simulated telehealth serious illness conversation visit

"The study team will instruct the participant to relax, and record biometric data for a total 7 minutes (the beginning two minutes is to allow for physiologic adaptation).~Simulated Encounter The study team will train experienced actors in the same case, a patient with a metastatic soft tissue sarcoma already on second-line chemotherapy. The physicians will receive a simulated medical file that contains a prognosis in a single format: a range-based, time prognosis (e.g. months to a year). The actor script and medical file will be developed by a multidisciplinary team (e.g. oncologist, palliative care, emotion scientist). The encounter will occur via tele-video platform (ZOOM®) and will be video-recorded. During the encounter participant physicians will wear three biometric sensors."

Trial Locations (1)

03766

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT05365763 - Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation | Biotech Hunter | Biotech Hunter